Home / Markets / News / Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs

Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs

Shares of Glenmark Pharma, Granules India, Divi's Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday's intra-day trade

SI Reporter |Business Standard | Mumbai
Premium
Nifty Pharma outshines benchmarks, up 2%; Cipla, Sun Pharma hit 52-wk highs

3 min read Last Updated : Oct 03 2022 | 12:51 PM IST
Follow Us

Listen to This Article

Shares of pharmaceutical companies were in focus as frontline stocks rallied up to 6 per cent in Monday's intra-day trade, due to strong business outlook. At 12:12 PM, the Nifty Pharma, and the S&P BS

Topics :Buzzing stocksCiplaSun PharmaPharma stocksNifty PharmaBSE NSE

First Published: Oct 03 2022 | 12:19 PM IST

Also Read

Cipla Q1 revenue may be muted on high base, low Covid drug sales: Analysts

Sun Pharma's Q1 margins likely to be hit on elevated input costs: Analysts

Sun Pharma Q1 net profit soars 43% YoY to Rs 2,061 cr; revenue up 10%

Lupin slips 9%, hits 2-year low on disappointing March quarter results

Sun Pharma stock likely to keep shining amid global specialty scale-up

RIL, ONGC, OIL: Will gas price hike fire up a bull phase in related stocks?

Nykaa soars 11% after board approves 5:1 bonus share

RITES hits all-time high on healthy outlook; stock climbs 15% in 3 days

ONGC, Oil India to gain most from gas price hike; IGL worst hit: Analysts

Chalet Hotels up 6%, hits 52-week high in a weak market on ratings upgrade

Next Story